QR-koda

Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy

Background: The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher rate of adverse events. We sought to compare 1-year outcomes of percutaneous...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Kush P. Patel, MBBS, Alexandra J. Lansky, MD, Dean J. Kereiakes, MD, Stephan Windecker, MD, Ecaterina Cristea, MD, Cody Pietras, BA, Ovidiu Dressler, MD, M. Ozgu Issever, MS, Michael Curtis, MD, Barry Bertolet, MD, James P. Zidar, MD, Pieter C. Smits, MD, Victor Alfonso Jiménez Díaz, MD, Brent McLaurin, MD, David A. Brogno, MD, Luc Janssens, MD, Mathias C. Vrolix, MD, Iván Gómez-Blázquez, MD, Zakir H. Sahul, MD, Ameer Kabour, MD, Luisa Salido, MD, Michael Cleman, MD, Shigeru Saito, MD, Martin B. Leon, MD, Andreas Baumbach, MD
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Elsevier 2022-01-01
Ráidu:Journal of the Society for Cardiovascular Angiography & Interventions
Fáttát:
Drug-eluting stent
Percutaneous coronary intervention
Coronary revascularization
Coronary artery disease
Acute coronary syndrome
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2772930321000041
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid